LMR Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,692
| Closed | -$705K | – | 1162 |
|
|
2025
Q1 | $705K | Buy |
+8,692
| New | +$705K | 0.01% | 461 |
|
|
2024
Q4 | – | Sell |
-89,778
| Closed | -$8.87M | – | 1076 |
|
|
2024
Q3 | $8.87M | Buy |
+89,778
| New | +$8.87M | 0.07% | 133 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 992 |
|
|
2024
Q1 | – | Sell |
-40,979
| Closed | -$3.66M | – | 1005 |
|
|
2023
Q4 | $3.66M | Sell |
40,979
-136,131
| -77% | -$12.2M | 0.04% | 199 |
|
|
2023
Q3 | $12.9M | Buy |
+177,110
| New | +$12.9M | 0.15% | 99 |
|
|
2023
Q2 | – | Sell |
-130,046
| Closed | -$9.91M | – | 1045 |
|
|
2023
Q1 | $9.91M | Sell |
130,046
-224,303
| -63% | -$17.1M | 0.15% | 146 |
|
|
2022
Q4 | $29.4M | Sell |
354,349
-395,060
| -53% | -$32.8M | 0.51% | 32 |
|
|
2022
Q3 | $59.4M | Sell |
749,409
-184,394
| -20% | -$14.6M | 1.09% | 3 |
|
|
2022
Q2 | $69.4M | Buy |
933,803
+285,547
| +44% | +$21.2M | 1.16% | 5 |
|
|
2022
Q1 | $58.3M | Buy |
648,256
+514,631
| +385% | +$46.3M | 0.68% | 14 |
|
|
2021
Q4 | $15M | Buy |
133,625
+3,262
| +3% | +$365K | 0.15% | 114 |
|
|
2021
Q3 | $16.4M | Sell |
130,363
-12,305
| -9% | -$1.55M | 0.18% | 105 |
|
|
2021
Q2 | $19.3M | Buy |
+142,668
| New | +$19.3M | 0.29% | 69 |
|